Cora Gold Limited (CORA.L)
GBp 2.4
(0.0%)
GBp 2.4
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -382 Thousand | -1.65 Million | -847 Thousand | -641 Thousand | -478 Thousand | -775 Thousand |
| Net Income | -2.95 Million | -2.51 Million | -1.76 Million | -727 Thousand | -1.47 Million | -837 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 85 Thousand | 111 Thousand | 244 Thousand | 138 Thousand | 25 Thousand | 21 Thousand |
| Change in working capital | 67 Thousand | -260 Thousand | 205 Thousand | -52 Thousand | 176 Thousand | 41 Thousand |
| Other non-cash items | 643 Thousand | 1.01 Million | 466 Thousand | - | 796 Thousand | - |
| Investing Cash Flow | -1.78 Million | -3.26 Million | -8.37 Million | -2.34 Million | -2.35 Million | -2.47 Million |
| Investments in PPE | -1.78 Million | -3.26 Million | -8.37 Million | -2.34 Million | -2.35 Million | -2.47 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.78 Million | - | - | - | - | - |
| Financing Cash Flow | 18.55 Million | - | 10.08 Million | 5.44 Million | 4.06 Million | 664 Thousand |
| Debt repayment | -15.25 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.92 Million | - | 10.21 Million | 5.46 Million | 4.21 Million | 694 Thousand |
| Other Financing Activities | -620 Thousand | - | -126 Thousand | -22 Thousand | -147 Thousand | -30 Thousand |
| Accounts receivables | 6000.00 | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 61 Thousand | - | - | - | - | - |
| Cash at beginning of period | 461 Thousand | 5.37 Million | 4.51 Million | 2.05 Million | 823 Thousand | 3.4 Million |
| Cash at end of period | 16.85 Million | 461 Thousand | 5.37 Million | 4.51 Million | 2.05 Million | 823 Thousand |
| Capital Expenditure | -1.78 Million | -3.26 Million | -8.37 Million | -2.34 Million | -2.35 Million | -2.47 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 16.39 Million | -4.91 Million | 862 Thousand | 2.45 Million | 1.23 Million | -2.58 Million |
| Free Cash Flow | -2.16 Million | -4.91 Million | -9.22 Million | -2.98 Million | -2.83 Million | -3.24 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -369.23 Thousand | -2.95 Million | -272.94 Thousand | -2.11 Million | -2.51 Million | -1.32 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 85 Thousand | - | - | 111 Thousand | - |
| Change in working capital | 74.32 Thousand | 67 Thousand | -35.72 Thousand | 89.2 Thousand | -260 Thousand | -145.8 Thousand |
| Other non-cash items | -513.13 Thousand | 643 Thousand | 178.22 Thousand | 1.84 Million | 1.01 Million | 767.91 Thousand |
| Investing Cash Flow | -660.98 Thousand | -1.78 Million | -614.45 Thousand | -810.91 Thousand | -3.26 Million | -941.13 Thousand |
| Investments in PPE | -660.98 Thousand | -1.78 Million | -614.45 Thousand | -810.91 Thousand | -3.26 Million | -941.13 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -10.26 Million | 18.55 Million | -770.16 Thousand | 15.58 Million | - | - |
| Debt repayment | -10.25 Million | -15.25 Million | -727.3 Thousand | -12.87 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -5534.54 | 3.92 Million | -42.85 Thousand | 2.7 Million | - | - |
| Other Financing Activities | - | - | - | 1.00 | - | - |
| Accounts receivables | 49.02 Thousand | - | -27.64 Thousand | 32.43 Thousand | - | 49.48 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 25.3 Thousand | - | -8081.19 | 56.76 Thousand | - | -195.29 Thousand |
| Cash at beginning of period | 13.21 Million | 461 Thousand | 14.54 Million | 383.24 Thousand | 5.37 Million | 1.66 Million |
| Cash at end of period | 1.64 Million | 16.85 Million | 13.21 Million | 14.54 Million | 461 Thousand | 383.24 Thousand |
| Capital Expenditure | -660.98 Thousand | -1.78 Million | -614.45 Thousand | -810.91 Thousand | -3.26 Million | -941.13 Thousand |
| Effect of forex changes on cash | - | - | - | -459.71 Thousand | - | - |
| Net cash flow / Change in cash | -11.57 Million | 16.39 Million | -1.32 Million | 14.16 Million | -4.91 Million | -1.28 Million |
| Free Cash Flow | -1.42 Million | -2.16 Million | -772.54 Thousand | -957.68 Thousand | -4.91 Million | -1.59 Million |
PPLPHARMA
ATAP
CBSM
FRERF
GOGL
OILRF